NHS National Pharmaceuticals Transition 2022_1
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £467,969,000 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Deadline | 21 Apr 2022 |
| Procedure | open |
| OCID | ocds-h6vhtk-032338 |
Awards (84)
This procurement was awarded to 42 suppliers. Values shown are per-award; the notice total is £467,969,000.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Accord-UK Ltd shared | £39,636,345 | 18 Jul 2022 | active |
| Accord-UK Ltd shared | · | · | active |
| Alturix shared | £39,636,345 | 18 Jul 2022 | active |
| Alturix shared | · | · | active |
| Amarox Limited shared | £39,636,345 | 18 Jul 2022 | active |
| Amarox Limited shared | · | · | active |
| Aspen Pharmacare UK Limited shared | £39,636,345 | 18 Jul 2022 | active |
| Aspen Pharmacare UK Limited shared | · | · | active |
| B. Braun Medical Limited shared | £39,636,345 | 18 Jul 2022 | active |
| B. Braun Medical Limited shared | · | · | active |
| Celix Pharma Ltd. shared | £39,636,345 | 18 Jul 2022 | active |
| Celix Pharma Ltd. shared | · | · | active |
| Chiesi Limited shared | £39,636,345 | 18 Jul 2022 | active |
| Chiesi Limited shared | · | · | active |
| Clinigen Healthcare Limited shared | £39,636,345 | 18 Jul 2022 | active |
| Clinigen Healthcare Limited shared | · | · | active |
| Consilient Health Ltd shared | £39,636,345 | 18 Jul 2022 | active |
| Consilient Health Ltd shared | · | · | active |
| Day Lewis Medical Ltd shared | £39,636,345 | 18 Jul 2022 | active |
| Day Lewis Medical Ltd shared | · | · | active |
| Dr.Reddy's Laboratories (UK) Limited shared | £39,636,345 | 18 Jul 2022 | active |
| Dr.Reddy's Laboratories (UK) Limited shared | · | · | active |
| ennogen healthcare ltd shared | £39,636,345 | 18 Jul 2022 | active |
| ennogen healthcare ltd shared | · | · | active |
| Flexipharm Austrading Limited shared | £39,636,345 | 18 Jul 2022 | active |
| Flexipharm Austrading Limited shared | · | · | active |
| FLYNN PHARMA LTD shared | £39,636,345 | 18 Jul 2022 | active |
| FLYNN PHARMA LTD shared | · | · | active |
| Fresenius Kabi Limited shared | £39,636,345 | 18 Jul 2022 | active |
| Fresenius Kabi Limited shared | · | · | active |
| Glenmark Pharmaceuticals Europe Limited shared | £39,636,345 | 18 Jul 2022 | active |
| Glenmark Pharmaceuticals Europe Limited shared | · | · | active |
| Intrapharm Laboratories Ltd shared | £39,636,345 | 18 Jul 2022 | active |
| Intrapharm Laboratories Ltd shared | · | · | active |
| Kent Pharma Ltd shared | £39,636,345 | 18 Jul 2022 | active |
| Kent Pharma Ltd shared | · | · | active |
| Macure Pharma ApS shared | £39,636,345 | 18 Jul 2022 | active |
| Macure Pharma ApS shared | · | · | active |
| medac Pharma LLP shared | £39,636,345 | 18 Jul 2022 | active |
| medac Pharma LLP shared | · | · | active |
| Mercury Pharmaceuticals Limited shared | £39,636,345 | 18 Jul 2022 | active |
| Mercury Pharmaceuticals Limited shared | · | · | active |
| Milpharm Ltd/aurobinbdo shared | £39,636,345 | 18 Jul 2022 | active |
| Milpharm Ltd/aurobinbdo shared | · | · | active |
| Morningside Pharmaeuticals shared | £39,636,345 | 18 Jul 2022 | active |
| Morningside Pharmaeuticals shared | · | · | active |
| Mylan shared | £39,636,345 | 18 Jul 2022 | active |
| Mylan shared | · | · | active |
| Napp Pharmaceuticals Ltd shared | £39,636,345 | 18 Jul 2022 | active |
| Napp Pharmaceuticals Ltd shared | · | · | active |
| Neon Healthcare Ltd shared | £39,636,345 | 18 Jul 2022 | active |
| Neon Healthcare Ltd shared | · | · | active |
| Norgine Pharmaceuticals Limited shared | £39,636,345 | 18 Jul 2022 | active |
| Norgine Pharmaceuticals Limited shared | · | · | active |
| Panpharma UK Limited shared | £39,636,345 | 18 Jul 2022 | active |
| Panpharma UK Limited shared | · | · | active |
| Pfizer Ltd shared | £39,636,345 | 18 Jul 2022 | active |
| Pfizer Ltd shared | · | · | active |
| Piramal Critical care Limited shared | £39,636,345 | 18 Jul 2022 | active |
| Piramal Critical care Limited shared | · | · | active |
| Ranbaxy UK shared | £39,636,345 | 18 Jul 2022 | active |
| Ranbaxy UK shared | · | · | active |
| Relonchem Ltd shared | £39,636,345 | 18 Jul 2022 | active |
| Relonchem Ltd shared | · | · | active |
| Roche Products Ltd shared | £39,636,345 | 18 Jul 2022 | active |
| Roche Products Ltd shared | · | · | active |
| Roma Pharmaceuticals Limited shared | £39,636,345 | 18 Jul 2022 | active |
| Roma Pharmaceuticals Limited shared | · | · | active |
| Rosemont Pharmaceuticals Limited shared | £39,636,345 | 18 Jul 2022 | active |
| Rosemont Pharmaceuticals Limited shared | · | · | active |
| Sandoz Ltd shared | £39,636,345 | 18 Jul 2022 | active |
| Sandoz Ltd shared | · | · | active |
| Selective Supplies Ltd. shared | £39,636,345 | 18 Jul 2022 | active |
| Selective Supplies Ltd. shared | · | · | active |
| Sintetica Ltd shared | £39,636,345 | 18 Jul 2022 | active |
| Sintetica Ltd shared | · | · | active |
| Teva UK Limited shared | £39,636,345 | 18 Jul 2022 | active |
| Teva UK Limited shared | · | · | active |
| Tillomed Laboratories ltd shared | £39,636,345 | 18 Jul 2022 | active |
| Tillomed Laboratories ltd shared | · | · | active |
| Wockhardt UK Limited shared | £39,636,345 | 18 Jul 2022 | active |
| Wockhardt UK Limited shared | · | · | active |
| Zentiva Pharma UK Ltd shared | £39,636,345 | 18 Jul 2022 | active |
| Zentiva Pharma UK Ltd shared | · | · | active |
description
NHS National Pharmaceuticals Transition 2022_1<br/>Potential periods of call-offs under the<br/>framework agreement:<br/>Transition:<br/>CESW: 29/07/2022 to 30/09/2023 (14<br/>months)<br/>LSNE: 29/07/2022 to 31/05/2024 (22<br/>months)<br/>NWLN: 29/07/2022 to 31/01/2023 (6months)<br/>Oral (plus non-parenteral) Products: All<br/>regions: 29/07/2022 to 31/05/2024 (22<br/>months)<br/>Hospital Only Products:<br/>CESW: 29/07/2022 to 30/09/2023 (14<br/>months)<br/>LSNE: 29/07/2022 to 31/05/2024 (22<br/>months)<br/>NWLN: 29/07/2022 to 31/01/2023 (6<br/>months)
documents
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb24/evB8b8Gkut9SP76SD0jVNTfm83MXFQoIabNgfEGAOd0
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb25/ebTSPjhvObmcnig4i.7lbWGsT45ss8jcJtQT0zoNRNU
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb26/yvqgp3.WSAYPJ57CmRlyHnpKkqAN08.23.nERDLK4CU
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2d/hClzb_TqTbdzM9q5xeEeWZBhcICRd14htDXLfdNULUw
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2E/pJ5gOOJGSelwGWyiB.qQKvlIDMxRqr5n_9M.ySxMBLI
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2e/y87p3nOERZS7UiSzi_7y.EaN0L_Od3NwMnBx98qAgk4
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2F/cOg8CjvacGGjuG1OMH5EuBICDrBp5lTrRnl1dscGTwg
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2f/_J5KU.TO3C01GXtTb59L7AfJ_oCOSi5PHKU_T70zVqg
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2G/_4YZMvnFYqEzphU46LVoo8GAnm6taHFJD3OFDe9aAjs
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2i/Vjj5x_19ZWuzEG4r1V8sws0YDwiAPgiRt_zHsGagDzg
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2j/A9.eKbRY5JwiPURdwaT3hbrEG49lEL90K5R6e5ijwoc
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2k/QyHWHOmm3s7M4OM9DVVPlxwPtjUXjGNDelWUEOwfkIU
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2n/so017jhuxywIWlKdR6PNFM9WklE7Im3B6Xmk9z.rdfA
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2o/HndL4pvBUmOWROvV28cEiRPX5rHYtfonRVMgI6y2kf0
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2p/Eng2.ORgPz.XA50ZZoiB2DPcJ1P4A.TO4tz2kthw95w
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2s/nD3VJF8W.kKloRKR4ReyOpR0Yg_dBX4oCM5z4TiwoLA
- https://www.contractsfinder.service.gov.uk/Notice/2d79e13e-096b-49e8-92f1-6b1ceed112ed , tenderNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
5 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 10 Dec 2021 | Planning (planning) | · | 595cb90f-7cae-41cb-96e9-9bd665159f74-493028 |
| 17 Mar 2022 | Contract notice (F02) | Earlier regulations | 007326-2022 |
| 17 Mar 2022 | Tender (tender) | · | 2d79e13e-096b-49e8-92f1-6b1ceed112ed-519371 |
| 12 Aug 2022 | Contract award notice (F03) | Earlier regulations | 022307-2022 |
| 12 Aug 2022 | Award (award) | · | 55810407-e268-4cea-a711-fc4b25667724-563472 |
more from NHS England
- Urgent Award - haematological screening · £16,202 · 29 Jul 2026
- HSCN-AWS Connectivity Service for Spine · £228,060 · 29 Jul 2026
- Incentive Voucher Provider · £60,000 · 29 Jul 2026
- CRM for NHSE participant/candidate data 26-27 · £56,640 · 28 Jul 2026
- Wayfinder and First Contact Digital Clinical Support 2026-27 · £748,000 · 23 Jul 2026
- Support Services for PPM application · £860,000 · 22 Jul 2026
- Digital Maturity Assessment · 21 Jul 2026
- Integrated Healthcare Services to Haslar Immigration Removal Centre (IRC) · £19,052,186 · 13 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.